Shandong Sito Bio-technology Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 725.008 million compared to CNY 786.794 million a year ago. Operating loss was CNY 54.045 million compared to operating Income of CNY 96.717 million a year ago. Net loss was CNY 49.125 million compared to net income of CNY 83.229 million a year ago. Basic loss per share from continuing operations was CNY 0.4595 compared to basic earnings per share from continuing operations of CNY 0.7779 a year ago. Diluted loss per share from continuing operations was CNY 0.4558 compared to diluted earnings per share from continuing operations of CNY 0.7797 a year ago.